
Pavlos Msaouel/LinkedIn
Jul 4, 2025, 15:52
Pavlos Msaouel: IVORY Trial of Ivonescimab in Metastatic Clear Cell Kidney Cancer is Now Enrolling
Pavlos Msaouel, Assistant Professor of Genitourinary Medical Oncology at MD Anderson Cancer Center, shared a post on X:
“Now enrolling MD Anderson Cancer Center: IVORY trial of ivonescimab (first-in-class PD1×VEGF bispecific) in metastatic clear cell Kidney Cancer after prior IO±TKI. Hypothesis: Cooperative inhibition of PD1/VEGF signaling will restore treatment sensitivity.”
More posts featuring Pavlos Msaouel.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 4, 2025, 15:49
Jul 4, 2025, 15:45
Jul 4, 2025, 15:43
Jul 4, 2025, 15:14
Jul 4, 2025, 14:05
Jul 4, 2025, 10:23